ES2039221T3 - Procedimiento para producir derivados de piridazinona. - Google Patents

Procedimiento para producir derivados de piridazinona.

Info

Publication number
ES2039221T3
ES2039221T3 ES87113115T ES87113115T ES2039221T3 ES 2039221 T3 ES2039221 T3 ES 2039221T3 ES 87113115 T ES87113115 T ES 87113115T ES 87113115 T ES87113115 T ES 87113115T ES 2039221 T3 ES2039221 T3 ES 2039221T3
Authority
ES
Spain
Prior art keywords
group
piridazinone
derivatives
procedure
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87113115T
Other languages
English (en)
Inventor
Kikuo Yasuda
Kenyu Shibata
Seijiro Honma
Toshimi Seki
Kohichi Hasumi
Takeshi Masuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Teikoku Hormone Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Hormone Manufacturing Co Ltd filed Critical Teikoku Hormone Manufacturing Co Ltd
Application granted granted Critical
Publication of ES2039221T3 publication Critical patent/ES2039221T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

LA INVENCION SE REFIERE A UN DERIVADO DE PIRIDAZINONA REPRESENTADO POR LA FORMULA GENERAL (I) EN LA QUE R1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO METILO, DE R2,R3 Y R4 UNO REPRESENTA UN ATOMO DE HIDROGENO Y LOS OTROS DOS REPRESENTAN UN GRUPO ALQUILO DE CADENA CORTA,UN GRUPO TRIFLUORMETILO, UN ATOMO DE HALOGENO, UN GRUPO CIANO O UN GRUPO NITRO. TAMBIEN SE REFIERE LA INVENCION A UNA SAL DEL CITADO COMPUESTO DE FORMULA (I). LOS COMPUESTOS SON UTILES COMO AGENTES ANTIHIPERTENSIVOS.
ES87113115T 1986-09-08 1987-09-08 Procedimiento para producir derivados de piridazinona. Expired - Lifetime ES2039221T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20967386 1986-09-08

Publications (1)

Publication Number Publication Date
ES2039221T3 true ES2039221T3 (es) 1996-07-16

Family

ID=16576711

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87113115T Expired - Lifetime ES2039221T3 (es) 1986-09-08 1987-09-08 Procedimiento para producir derivados de piridazinona.

Country Status (12)

Country Link
US (1) US4843072A (es)
EP (1) EP0259835B1 (es)
JP (1) JPH0629254B2 (es)
KR (1) KR920002297B1 (es)
AT (2) ATE71619T1 (es)
AU (1) AU598583B2 (es)
CA (1) CA1324380C (es)
DE (1) DE3776044D1 (es)
ES (1) ES2039221T3 (es)
GR (1) GR3003776T3 (es)
IN (1) IN165718B (es)
NZ (1) NZ221699A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3934436A1 (de) * 1989-06-01 1991-04-18 Thomae Gmbh Dr K 2-hydroxy-n-propylamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JP2799186B2 (ja) * 1989-06-02 1998-09-17 帝国臓器製薬株式会社 光学活性ピリダジノン誘導体
US5221674A (en) * 1989-06-19 1993-06-22 Teikoku Hormone Mfg. Co., Ltd. Pyridazinone derivatives
NZ234087A (en) * 1989-06-19 1991-08-27 Teikoku Hormone Mfg Co Ltd 2-(3-aryloxy(2-hydroxy-propylamino))-2-methylpropyl- aminophenyl pyridazine derivatives
KR910004574A (ko) * 1989-08-10 1991-03-28 글락소 인크 강심 작용 및 베타 차단 작용을 갖는 피리다지논류
US5204463A (en) * 1989-08-10 1993-04-20 Glaxo Inc. Substituted methoxyphenyl-4,5 dihydro-3(2H)-pridazinones having cardiotonic and beta blocking activities
US5096904A (en) * 1989-09-01 1992-03-17 Glaxo Inc. Pyridazinones having cardiotonic and beta blocking activities
US5153209A (en) * 1989-09-22 1992-10-06 Glaxo Inc. Pyridone nitriles useful in treating cardiovascular disease
US5051431A (en) * 1989-09-22 1991-09-24 Glaxo Inc. Pyridone nitriles useful in treating cardiovascular disease
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
JPH0995449A (ja) * 1995-09-29 1997-04-08 Teikoku Hormone Mfg Co Ltd 緑内障治療剤
CA2588947A1 (en) * 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
RS52626B (en) * 2006-07-25 2013-06-28 Cephalon Inc. PYRIDIZINONA DERIVATIVES
JP6041303B2 (ja) * 2012-12-13 2016-12-07 Ｋｔｎバイオテック株式会社 新規抗癌剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1488330A (en) * 1973-12-19 1977-10-12 Smith Kline French Lab Dihydropyridazinones
IE42214B1 (en) * 1974-06-18 1980-07-02 Smith Kline French Lab Hydrazinopyredazines
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
JPS58146570A (ja) * 1982-02-25 1983-09-01 Teikoku Hormone Mfg Co Ltd ピリダジノン誘導体
US4711887A (en) * 1982-04-23 1987-12-08 Imperial Chemical Industries Plc Hydrazinopyridazine compounds
EP0097202B1 (en) * 1982-06-23 1987-11-19 Teikoku Hormone Mfg. Co., Ltd. Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament
DE3302442A1 (de) * 1983-01-26 1984-07-26 Basf Ag, 6700 Ludwigshafen Neue pyridazinone, verfahren zu ihrer herstellung, diese verbindungen enthaltende therapeutische mittel und deren verwendung
GB8323553D0 (en) * 1983-09-02 1983-10-05 Smith Kline French Lab Pharmaceutical compositions
GB8412864D0 (en) * 1984-05-19 1984-06-27 Smith Kline French Lab Chemical compounds
CA1251448A (en) * 1985-03-27 1989-03-21 William J. Coates Pyridazinone derivatives

Also Published As

Publication number Publication date
IN165718B (es) 1989-12-23
ATA49688A (de) 1989-03-15
EP0259835A2 (en) 1988-03-16
ATE71619T1 (de) 1992-02-15
NZ221699A (en) 1990-03-27
US4843072A (en) 1989-06-27
EP0259835A3 (en) 1989-03-15
AT389108B (de) 1989-10-25
KR880003920A (ko) 1988-05-31
AU598583B2 (en) 1990-06-28
JPS63183568A (ja) 1988-07-28
KR920002297B1 (ko) 1992-03-21
AU7810787A (en) 1988-03-10
DE3776044D1 (de) 1992-02-27
CA1324380C (en) 1993-11-16
EP0259835B1 (en) 1992-01-15
GR3003776T3 (es) 1993-03-16
JPH0629254B2 (ja) 1994-04-20

Similar Documents

Publication Publication Date Title
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
NO992549D0 (no) Sukkerforbindelse, geleringsmiddel og fremgangsmÕte for fremstilling derav
ES2054899T3 (es) Derivados de 2'-desoxi-5-fluorouridina.
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
ES8700228A1 (es) Un procedimiento para producir derivados de propargiloxiacetonitrilo sustituido.
ES519650A0 (es) Un procedimiento para obtener derivados de indanilbenzamida.
DK415789D0 (da) Tetracykliske antidepressive midler
DK412581A (da) Ethenylimidazolderivater og fremgangsmaade til fremstilling heraf
DE3667788D1 (de) Diphenyletherherbizide.
ES2068663T3 (es) Procedimiento para la preparacion de compuestos de piridina sustituidos con halogenosulfonilo.
ES2035849T3 (es) Procedimiento para preparar derivados de eter difenilico.
DK0979822T3 (da) Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner
ES2002325A6 (es) Un procedimiento para preparar un derivado de dihidropiridina
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
MY104164A (en) Heterocyclic compounds.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 259835

Country of ref document: ES

FG2A Definitive protection

Ref document number: 0259835

Country of ref document: ES